⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9195664 | 0.93 | — | — | |
| SCHEMBL9197622 | 0.88 | SOAT1 (0.50) | — | |
| SCHEMBL9516984 | 0.80 | SOAT1 (0.52) | — | |
| SCHEMBL9800911 | 0.75 | — | — | |
| SCHEMBL9800920 | 0.75 | — | — | |
| SCHEMBL9514978 | 0.74 | KIF11 (0.44) | — | |
| SCHEMBL13480578 | 0.74 | SMN1; SMN2 (0.58) | — | |
| SCHEMBL10402548 | 0.72 | LMNA (0.56) | — | |
| SCHEMBL8321568 | 0.71 | — | — | |
| SCHEMBL9848433 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0344425-B1 | N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents | WARNER LAMBERT CO (US) | 1993-12-08 | — | — | EP | disclosed |
| EP-0344425-A2 | N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents | WARNER-LAMBERT COMPANY (US) | 1989-12-06 | — | — | EP | disclosed |